Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Curevac N.V.
(NQ:
CVAC
)
2.600
+0.070 (+2.77%)
Official Closing Price
Updated: 4:15 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
609,966
Open
2.600
Bid (Size)
2.430 (1)
Ask (Size)
2.680 (3)
Prev. Close
2.530
Today's Range
2.510 - 2.625
52wk Range
2.360 - 12.36
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024
April 18, 2024
Via
ACCESSWIRE
CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
April 16, 2024
Via
ACCESSWIRE
Performance
YTD
-37.95%
-37.95%
1 Month
-17.46%
-17.46%
3 Month
-31.58%
-31.58%
6 Month
-52.47%
-52.47%
1 Year
-66.15%
-66.15%
More News
Read More
Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
April 12, 2024
Via
Benzinga
CureVac, GS Partner Release Data On Influenza Vaccine Study
April 04, 2024
Via
Benzinga
CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
April 04, 2024
Via
ACCESSWIRE
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business Update
November 14, 2023
Via
ACCESSWIRE
Why Biopharmaceutical Player CureVac Shares Are Rising Today
January 05, 2024
Via
Benzinga
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform
January 05, 2024
Via
ACCESSWIRE
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 19, 2023
Via
Benzinga
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
December 19, 2023
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday
December 19, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE
December 19, 2023
Via
ACCESSWIRE
Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology
November 15, 2023
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
Earnings Scheduled For November 14, 2023
November 14, 2023
Via
Benzinga
CureVac Announces Solid Progress in Phase 2 COVID-19 and Seasonal Flu Clinical Development Programs in Collaboration with GSK
November 01, 2023
Via
ACCESSWIRE
Why CureVac Stock Plunged Today
September 29, 2023
Via
The Motley Fool
Topics
Lawsuit
Exposures
Financial
Legal
3 Stocks to Buy For the COVID Resurgence
September 06, 2023
Via
MarketBeat
Exposures
COVID-19
Product Safety
CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update
August 17, 2023
Via
ACCESSWIRE
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 28, 2023
Via
Benzinga
CureVac Announces Dosing of First Participant in Phase 2 Study of Modified COVID-19 mRNA Vaccine Candidates Developed in Collaboration with GSK
August 01, 2023
Via
ACCESSWIRE
CureVac Announces Update to the Management Team
July 14, 2023
Via
ACCESSWIRE
CureVac Strengthens Ongoing Patent Litigations Bringing Additional Cases Under New Intellectual Property Rights
July 13, 2023
Via
ACCESSWIRE
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
Via
Benzinga
Why Shares of CureVac Jumped This Week
June 23, 2023
Via
The Motley Fool
Why CureVac Stock Leaped 12% Higher Today
June 20, 2023
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.